RAP 0.00% 20.5¢ resapp health limited

Didn't both RAP products fail to meet expectations in clinical...

  1. 867 Posts.
    lightbulb Created with Sketch. 97
    Didn't both RAP products fail to meet expectations in clinical trials?

    And have a higher share price before the covid product ever existed?

    It's been well pumped under varying circumstances over the years I think 21c is a great result.


 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.